Tracking down metabolic vulnerabilities in CDK12-mutant prostate cancer

dc.contributor.author

Tu, Wei-Ling

dc.contributor.author

Wang, Mu-En

dc.contributor.author

Chen, Ming

dc.date.accessioned

2024-08-04T20:20:21Z

dc.date.available

2024-08-04T20:20:21Z

dc.date.issued

2024-08-01

dc.identifier.issn

2768-0622

dc.identifier.issn

2768-0622

dc.identifier.uri

https://hdl.handle.net/10161/31308

dc.language

en

dc.publisher

Wiley

dc.relation.ispartof

Clinical and Translational Discovery

dc.relation.isversionof

10.1002/ctd2.345

dc.rights.uri

https://creativecommons.org/licenses/by-nc/4.0

dc.title

Tracking down metabolic vulnerabilities in CDK12-mutant prostate cancer

dc.type

Journal article

duke.contributor.orcid

Chen, Ming|0000-0002-3470-1062

pubs.issue

4

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Cell Biology

pubs.organisational-group

Pathology

pubs.organisational-group

Duke Cancer Institute

pubs.publication-status

Accepted

pubs.volume

4

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2024-CDK12 commentary.pdf
Size:
396.63 KB
Format:
Adobe Portable Document Format
Description:
Published version